{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:05:28Z","timestamp":1781499928049,"version":"3.54.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.psc.2005.02.004","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T19:42:19Z","timestamp":1113507739000},"page":"301-323","source":"Crossref","is-referenced-by-count":11,"title":["Anticonvulsants in Bipolar Disorder"],"prefix":"10.1016","volume":"28","author":[{"given":"Vivek","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Muzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.psc.2005.02.004_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1034\/j.1399-5618.2001.30501.x","article-title":"The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder","volume":"3","author":"Chengappa","year":"2001","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.psc.2005.02.004_bib2","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1111\/j.1528-1157.1983.tb04652.x","article-title":"Treatment of mood disorder with antiepileptic medications: clinical and theoretical implications","volume":"2","author":"Post","year":"1983","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.psc.2005.02.004_bib3","first-page":"941","article-title":"New anticonvulsant medication uses in bipolar disorder","author":"Wang","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.psc.2005.02.004_bib4","first-page":"707","article-title":"Action neuropsychotrope d'un nouvel anti-epileplique: le depamide","volume":"1","author":"Lambert","year":"1966","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.psc.2005.02.004_bib5","first-page":"287","article-title":"On a possible role of GABA in mania: therapeutic efficacy of sodium valproate","volume":"26","author":"Emrich","year":"1981","journal-title":"Adv Biochem Psychopharmacol"},{"key":"10.1016\/j.psc.2005.02.004_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania: a placebo-controlled study","volume":"48","author":"Pope","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jama.1994.03520130039028","article-title":"Efficacy of divalproex vs lithium and placebo in mania","volume":"272","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.psc.2005.02.004_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000118970","article-title":"Valproate as a loading treatment in acute mania","volume":"27","author":"McElroy","year":"1993","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.psc.2005.02.004_bib9","first-page":"103","article-title":"Illness characteristics of patients in clinical drug studies of mania","volume":"31","author":"Bowden","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.psc.2005.02.004_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania: treatment response to lithium or divalproex","volume":"54","author":"Swann","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.149.1.108","article-title":"A double-blind comparison of valproate and lithium in the treatment of acute mania","volume":"149","author":"Freeman","year":"1992","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.psc.2005.02.004_bib12","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4088\/JCP.v63n1210","article-title":"A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder","volume":"63","author":"Zajecka","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Risperidone plus mood stabilizer versus placebo plus mood stabilizer for acute mania of bipolar disorder: a double-blind comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","article-title":"Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial","volume":"182","author":"Yatham","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2005.02.004_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004714-200004000-00012","article-title":"Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study","volume":"20","author":"Muller-Oerlinghausen","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psc.2005.02.004_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1176\/ajp.157.1.124","article-title":"Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression","volume":"157","author":"Young","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2005.02.004_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-5618.2003.00031.x","article-title":"Valproate","volume":"5","author":"Bowden","year":"2003","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.psc.2005.02.004_bib19","unstructured":"Sachs G, Altshuler L, Ketter T, et al. Divalproex versus placebo for the treatment of bipolar depression. Presented at the 40th Annual Meeting of the American College of Neuropsychopharmacology. Waikoloa, Hawaii, December 9\u201313, 2001."},{"issue":"4","key":"10.1016\/j.psc.2005.02.004_bib20","first-page":"647","article-title":"Valproate as an antidepressant in major depressive disorder","volume":"32","author":"Davis","year":"2004","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"10.1016\/j.psc.2005.02.004_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00004714-200202000-00021","article-title":"Valproate therapy for chronic, combat-induced posttraumatic stress disorder","volume":"22","author":"Petty","year":"2002","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.psc.2005.02.004_bib22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/sj.npp.1300190","article-title":"Maintenance efficacy of divalproex in the prevention of bipolar depression","volume":"28","author":"Gyulai","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psc.2005.02.004_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2005.02.004_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.153.6.765","article-title":"Relationship of serum valproate concentration to response in mania","volume":"153","author":"Bowden","year":"1996","journal-title":"Am J of Psychiatry"},{"issue":"9","key":"10.1016\/j.psc.2005.02.004_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ps.51.9.1179","article-title":"Computerized monitoring of valproate and physician responsiveness to laboratory studies as a quality indicator","volume":"51","author":"Luchins","year":"2000","journal-title":"Psychiatr Serv"},{"issue":"S2","key":"10.1016\/j.psc.2005.02.004_bib26","first-page":"25","article-title":"Pharmacokinetics, drug interactions, and tolerability of valproate","volume":"37","author":"DeVane","year":"2003","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"10.1016\/j.psc.2005.02.004_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate","volume":"22","author":"Acharya","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.psc.2005.02.004_bib28","series-title":"Textbook of psychopharmacology","first-page":"581","article-title":"Carbamazepine and oxcarbazepine","author":"Ketter","year":"1998"},{"issue":"S1","key":"10.1016\/j.psc.2005.02.004_bib29","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0165-0327(00)00177-4","article-title":"A review of randomized, controlled clinical trials in acute mania","volume":"59","author":"Keck","year":"2000","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.psc.2005.02.004_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"J Clin Psychiat"},{"issue":"7","key":"10.1016\/j.psc.2005.02.004_bib31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ajp.137.7.782","article-title":"Carbamazepine in manic-depressive illness: a new treatment","volume":"137","author":"Ballenger","year":"1980","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2005.02.004_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00004714-200304000-00011","article-title":"Antidepressant properties of anticonvulsant drugs for bipolar disorder","volume":"23","author":"Ernst","year":"2003","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psc.2005.02.004_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/ajp.143.1.29","article-title":"Antidepressant effects of carbamazepine","volume":"143","author":"Post","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1192\/S0007125000146525","article-title":"Re-evaluating carbamazepine prophylaxis in bipolar disorder","volume":"170","author":"Post","year":"1997","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00431111","article-title":"A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness","volume":"73","author":"Okuma","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.psc.2005.02.004_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-199812000-00007","article-title":"Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder","volume":"18","author":"Greil","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.psc.2005.02.004_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S1461145703003535","article-title":"Acute and maintenance treatment with mood stabilizers","volume":"6","author":"Bowden","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"issue":"11","key":"10.1016\/j.psc.2005.02.004_bib38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/JCP.v58n1102","article-title":"Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder","volume":"58","author":"Denicoff","year":"1997","journal-title":"J Clin Psychiatry"},{"issue":"S1","key":"10.1016\/j.psc.2005.02.004_bib39","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0165-0327(02)00338-5","article-title":"Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: review of efficacy and tolerability","volume":"72","author":"Hellewell","year":"2002","journal-title":"J Affect Disord"},{"issue":"S5","key":"10.1016\/j.psc.2005.02.004_bib40","first-page":"83","article-title":"Studies with oxcarbazepine in acute mania","author":"Emrich","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.psc.2005.02.004_bib41","series-title":"Trileptal [package insert]","year":"2000"},{"issue":"1\u20132","key":"10.1016\/j.psc.2005.02.004_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-1211(02)00080-3","article-title":"Antiepileptic drugs in psychiatry-focus on randomized controlled trial","volume":"50","author":"Muzina","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.psc.2005.02.004_bib43","series-title":"Physicians' Desk Reference","year":"2005"},{"issue":"1","key":"10.1016\/j.psc.2005.02.004_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(94)90091-4","article-title":"Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis","volume":"19","author":"Van Parys","year":"1994","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.psc.2005.02.004_bib45","unstructured":"Bowden C, Calabrese R, Ascher J, et al. Spectrum of efficacy of lamotrigine in bipolar disorder: overview of double-blind, placebo-controlled studies. Abstracts of the 2000 Annual Meeting of the American College of Neuropsychopharmacology (ACNP). Nashville, TN: ACNP."},{"key":"10.1016\/j.psc.2005.02.004_bib46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/14656566.3.10.1513","article-title":"Lamotrigine in the treatment of bipolar disorder","volume":"10","author":"Bowden","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.psc.2005.02.004_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders","volume":"20","author":"Frye","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.psc.2005.02.004_bib49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib50","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar i disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib51","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0924-977X(03)00079-8","article-title":"Latest maintenance data on lamotrigine in bipolar disorder","volume":"13","author":"Calabrese","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.psc.2005.02.004_bib52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind placebo-controlled prophylaxis study of lamotrigine in rapid cycling bipolar disorder","volume":"61","author":"Calabrese","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib53","series-title":"Lamictal [package insert]","year":"2003"},{"issue":"11","key":"10.1016\/j.psc.2005.02.004_bib54","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.0013-9580.2004.451105.x","article-title":"The International Lamotrigine Pregnancy Registry Update for the Epilepsy Foundation","volume":"45","author":"Cunnington","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.psc.2005.02.004_bib55","series-title":"Pharmacotherapy\u2014a pathophysiologic approach","first-page":"1031","article-title":"Epilepsy","author":"Gidal","year":"2002"},{"key":"10.1016\/j.psc.2005.02.004_bib56","series-title":"Textbook of chopharmacology","first-page":"627","article-title":"Topiramate","author":"McElroy","year":"1998"},{"issue":"3","key":"10.1016\/j.psc.2005.02.004_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1399-5618.2002.01189.x","article-title":"Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study","volume":"4","author":"McIntyre","year":"2002","journal-title":"Bipolar Disord"},{"issue":"7","key":"10.1016\/j.psc.2005.02.004_bib58","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4088\/JCP.v64n0715","article-title":"1-year follow-up of patients treated with risperidone and topiramate for a manic episode","volume":"64","author":"Vieta","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2005.02.004_bib59","series-title":"Textbook of psychopharmacology","first-page":"607","article-title":"Gabapentin","author":"Frye","year":"1998"},{"issue":"3 Pt 2","key":"10.1016\/j.psc.2005.02.004_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1399-5618.2000.20305.x","article-title":"Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group","volume":"2","author":"Pande","year":"2000","journal-title":"Bipolar Disord"},{"issue":"4","key":"10.1016\/j.psc.2005.02.004_bib61","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004714-199908000-00010","article-title":"Treatment of social phobia with gabapentin: a placebo-controlled study","volume":"19","author":"Pande","year":"1999","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.psc.2005.02.004_bib62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0278-5846(94)90078-7","article-title":"The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania","volume":"18","author":"Kanba","year":"1994","journal-title":"Prog Neuropsychopharmacol"},{"issue":"14","key":"10.1016\/j.psc.2005.02.004_bib63","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1001\/jama.289.14.1820","article-title":"Zonisamide for weight loss in obese adults: a randomized controlled trial","volume":"289","author":"Gadde","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.psc.2005.02.004_bib64","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.yebeh.2004.08.009","article-title":"Monotherapy treatment of bipolar disorder with levetiracetam","volume":"5","author":"Kaufman","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"7","key":"10.1016\/j.psc.2005.02.004_bib65","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4088\/JCP.v64n0707","article-title":"Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design","volume":"64","author":"Grunze","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2005.02.004_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003088-200342010-00002","article-title":"Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures","volume":"42","author":"Fischer","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.psc.2005.02.004_bib67","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archneurpsyc.1943.02290150102005","article-title":"Attempts at treatment of schizophrenia and other non-epileptic psychoses with Dilantin","volume":"49","author":"Kalinowsky","year":"1943","journal-title":"Arch Neurol Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2005.02.004_bib68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1176\/appi.ajp.157.3.463","article-title":"Phenytoin as an antimanic anticonvulsant: a controlled study","volume":"157","author":"Mishory","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2005.02.004_bib69","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4088\/JCP.v64n0408","article-title":"Intravenous fosphenytoin in acute mania","volume":"64","author":"Applebaum","year":"2003","journal-title":"J Clin Psychiatry"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X05000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X05000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T09:53:02Z","timestamp":1550051582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X05000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0193953X05000262"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2005.02.004","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}